| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |